JMB-2403

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameJMB-2403
Drug Alias NameJMB-2403JMB24032403T62
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody
Mechanisms of ActionAnti-PD-1Anti-Interleukin-2 receptor beta chainAnti-Interleukin-2 receptor subunit gamma
TargetsProgrammed cell death protein 1Interleukin-2 receptor beta chainInterleukin-2 receptor subunit gamma
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Jiyu Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiyu Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A